Assuming research is required, the following results were found.

  • J.K. Rowling makes $18.8 million donation to multiple sclerosis research - WRBL

    / Updated: Sep 12, 2019 / 04:29 PM EDT LONDON (AP) – Harry Potter author J.K. Rowling has made a substantial donation for research into the treatment of multiple sclerosis at a center named after her late mother. The 15.3 million-pound ($18.8 million)...

    https://mschristian.org/index.php/blog/j-k-rowling-makes-18-8-million-donation-to-multiple-sclerosis-research-wrbl
  • New research to stop Multiple Sclerosis - WILX-TV

    LANSING, MI. (WILX) - Dr. Rany Aburashed at Memorial Healthcare in Owosso is conducting new research to potentially stop the progression of Multiple Sclerosis. A woman who witnessed the struggles of Multiple Sclerosis (MS) in a family member is now...

    https://mschristian.org/index.php/blog/new-research-to-stop-multiple-sclerosis-wilx-tv
  • Research Explores Cannabis as Treatment for MS, Alzheimer’s and Huntington’s Disease - Pain News Network

    By Pat Anson, PNN Editor The University of Alberta is partnering with a Canadian cannabis company in three research projects exploring the use of medical cannabis for the treatment of multiple sclerosis, Alzheimer’s and Huntington’s diseases. Atlas...

    https://mschristian.org/index.php/blog/research-explores-cannabis-as-treatment-for-ms-alzheimer-s-and-huntington-s-disease-pain-news-network
  • Multiple sclerosis: Helping cells to help themselves

    to the 'myelin sheath', a protective covering wrapped around nerve cells akin to insulation around an electrical wire. Researchers have discovered how the body initiates repair mechanisms which will limit the extent of any damage to this sheath. Their...

    https://mschristian.org/index.php/blog/multiple-sclerosis-helping-cells-to-help-themselves
  • Electronic Drug Delivery Systems Market Size Reach US$ 12.1 Billion by 2026 - Yahoo Finance

    by 2026 growing at a CAGR of 8.9% from forecast period 2019 to 2026. LOS ANGELES, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Electronic Drug...

    https://mschristian.org/index.php/blog/electronic-drug-delivery-systems-market-size-reach-us-12-1-billion-by-2026-yahoo-finance
  • Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 - Science

    and 101788/Z/13/Z (to D.F.Y. and R.E.R.)], Sir Jules Thorn Trust [12/JTA (to S.H.)], UK National Institute of Health Research [TRF-2016-09-002 (to T.A.B.)], NIHR Manchester Biomedical Resource Centre (to T.A.B.), Medical Research Foundation (to T.A.B.),...

    https://mschristian.org/index.php/blog/severe-type-i-interferonopathy-and-unrestrained-interferon-signaling-due-to-a-homozygous-germline-mutation-in-stat2-science
  • FDA approves immune-modulating therapy for treatment of multiple sclerosis

    26 2020 The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced clinical development for...

    https://mschristian.org/index.php/articles/2-uncategorised/10397-fda-approves-immune-modulating-therapy-for-treatment-of-multiple-sclerosis
  • NetNoggin® releases exploratory analysis "Healthcare Provider Needs in the NASH Market" - P&T Community

    nonalcoholic steatohepatitis (NASH), including nonalcoholic fatty liver (NAFL), market have multiple unmet needs within: Research of NASH (including NAFL) Pediatric nonalcoholic fatty liver disease (NAFLD) Diagnosis and screening Treatment and...

    https://mschristian.org/index.php/articles/2-uncategorised/9185-netnoggin-releases-exploratory-analysis-healthcare-provider-needs-in-the-nash-market-p-t-community
  • Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 - Science

    and 101788/Z/13/Z (to D.F.Y. and R.E.R.)], Sir Jules Thorn Trust [12/JTA (to S.H.)], UK National Institute of Health Research [TRF-2016-09-002 (to T.A.B.)], NIHR Manchester Biomedical Resource Centre (to T.A.B.), Medical Research Foundation (to T.A.B.),...

    https://mschristian.org/index.php/articles/2-uncategorised/9542-severe-type-i-interferonopathy-and-unrestrained-interferon-signaling-due-to-a-homozygous-germline-mutation-in-stat2-science
  • As MS research evolves, a new focus on brain preservation comes to light

    Dec 2019 - By MS Mindshift Brain preservation starts with understanding the key role the brain plays when it comes to multiple sclerosis (MS). There are 4 key areas to focus on, including how you can preserve your brain and its function by making...

    https://mschristian.org/index.php/articles/2-uncategorised/9692-as-ms-research-evolves-a-new-focus-on-brain-preservation-comes-to-light
  • A molecular switch for repairing damage in central nervous system disorders discovered

    turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis (MS), Mayo Clinic researchers discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy...

    https://mschristian.org/index.php/articles/2-uncategorised/9793-a-molecular-switch-for-repairing-damage-in-central-nervous-system-disorders-discovered
  • Molecular switch for repairing central nervous system disorders

    turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis (MS), Mayo Clinic researchers discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy...

    https://mschristian.org/index.php/articles/2-uncategorised/9808-molecular-switch-for-repairing-central-nervous-system-disorders
  • Experts evaluate options for treating cognitive deficits in multiple sclerosis

    Reviewed by Emily Henderson, B.Sc.Jun 16 2020 Experts in cognitive research evaluated the status of available treatments as well as promising strategies for treating cognitive deficits in multiple sclerosis. The article, "Treatment and management of...

    https://mschristian.org/index.php/experts-evaluate-options-for-treating-cognitive-deficits-in-multiple-sclerosis
  • MS: Paleo diet may reduce fatigue by improving cholesterol

    New research investigates the effect of following a Wahls paleo diet on fatigue in multiple sclerosis (MS). A diet rich in vegetables, fruit, meat, and fish may improve fatigue in MS. According to some estimates, at least two-thirds of people with MS...

    https://mschristian.org/index.php/articles/2-uncategorised/8297-ms-paleo-diet-may-reduce-fatigue-by-improving-cholesterol
  • New insights into how immune system and inflammation play a role in PD

    Reviewed by Kate Anderton, B.Sc. (Editor)Nov 14 2019 Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal...

    https://mschristian.org/index.php/articles/2-uncategorised/9293-new-insights-into-how-immune-system-and-inflammation-play-a-role-in-pd
  • MS: Common herpesvirus variant raises risk

    New research distinguishes between two similar variants of the human herpesvirus 6 and finds that one variant significantly increases the risk of developing multiple sclerosis (MS). Share on Pinterest Scientists have linked the Epstein-Barr virus...

    https://mschristian.org/index.php/articles/2-uncategorised/9447-ms-common-herpesvirus-variant-raises-risk
  • Primary Progressive Multiple Sclerosis Treatment Market Studied by 2019-2027 with Profiling Player - Market Research Sheets

    New Statistical Research for Primary Progressive Multiple Sclerosis Treatment market 2019 displays the latest industry insights with future trends and analysis of the products and services, enabling you to deeply penetrate the Primary Progressive...

    https://mschristian.org/index.php/blog/primary-progressive-multiple-sclerosis-treatment-market-studied-by-2019-2027-with-profiling-player-market-research-sheets
  • Can naltrexone help with multiple sclerosis (MS)?

    in low doses, has recently become a popular drug for treating multiple sclerosis. This is an off-label use, and research into its effectiveness is still underway. Multiple sclerosis (MS) is a disease that damages the nerve cells. As it progresses,...

    https://mschristian.org/index.php/blog/can-naltrexone-help-with-multiple-sclerosis-ms-1
  • How metabolites target brain-homing immune cells to treat multiple sclerosis

    Advanced Science Research Center, GC/CUNY. "How metabolites target brain-homing immune cells to treat multiple sclerosis: The discovery could lead to novel, more specific, and more effective MS therapies and a better understanding of how the disease...

    https://mschristian.org/index.php/blog/how-metabolites-target-brain-homing-immune-cells-to-treat-multiple-sclerosis
  • Read more about efforts to understand tissue damage in MS

    and the insulating tissue (myelin) that wraps around axons, disrupting nerve signal transmission. Driving solutions Research focusing on understanding the extent and causes of damage to the nervous system in MS is driving progress that will help us find...

    https://mschristian.org/index.php/blog/read-more-about-efforts-to-understand-tissue-damage-in-ms

Results 61 - 80 of 493